Genelabs reports lower Q3 loss
13th Nov 2006, 22:28 GMT
Genelabs posted a loss of $633,000 for Q3 ended 9/30/2006 compared with a loss of $2.8 mln a year ago in the same period.
Genelabs reports lower Q3 loss related news:
- Genelabs reports lower Q3 loss — Latest news from San Francisco Business Times
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006 — Partnerships/ Joint Ventures News from StratCenter.com
- Genelabs's Q3 loss shrinks as revenue more than doubles — Latest news from Silicon Valley/San Jose Business Journal
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Eddie Bauer reports deeper Q3 loss — Latest news from Puget Sound Business Journal (Seattle)
- ZIOPHARM Oncology Reports Q3 2006 Results — Pharmaceuticals News from StratCenter.com
- eGene Reports a Profitable Quarter Result and Revenue Increases 273% in Q3 2006 Compared to Q3 2005 — Operations-Related News from StratCenter.com
- Muzak narrows 3Q loss, names CFO — Latest news from Charlotte Business Journal
- SCM posts $3.9M loss in Q3 — Latest news from San Francisco Business Times
- Solexa Narrows 3Q Loss — Bio-Technology News from StratCenter.com
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies
- Kos' Swan Song